Stock Option Plans, Stock Grants, Stock Appreciation Rights and Employee Stock Purchase Plan (Tables)

12 Months Ended

Dec. 31, 2011

Amounts Charged to Expense for Stock-based Compensation

The amounts charged to expense for stock-based compensation for the years ended December 31, 2011, 2010 and 2009 is presented in the following table:

		September 30,			September 30,			September 30,
	Year Ended December 31,
In thousands	2011			2010			2009
Restricted stock units (1)	$	139		$	5,551		$	8,793
Directors restricted stock grants (2)		248			210			180
Employee stock purchase plan		173			221			178
Stock appreciation rights (3)		(100	)		(77	)		(420	)
Stock options		—			—			—
Total stock based compensation	$	460		$	5,905		$	8,731

(1) — The reduction in stock grant expense includes the reversal of previously recognized expense related to performance based awards that are not expected to vest.

(2) — Relates to non-employee directors serving on the Parent Company’s Board of Directors, all who have been elected by the Company's shareholders, as well as NUAL’s Board of Directors.

(3) — All issued stock appreciation rights were exercised during 2011. The Company will no longer issue awards from the Stock Appreciation Rights Plan as a result of the 2005 Amended and Restated Stock Incentive Plan.

Unvested Restricted Stock Grants Outstanding

Unvested restricted stock grants outstanding as of December 31, 2011, 2010 and 2009 are as follows:

		September 30,			September 30,			September 30,
	December 31,
	2011			2010			2009
Beginning balance		590,661			619,739			558,049
Granted		184,758			169,134			202,731
Vested		(172,731	)		(156,723	)		(104,677	)
Forfeited		(75,716	)		(41,489	)		(36,364	)
Ending balance		526,972			590,661			619,739

Stock Options Outstanding

Stock options outstanding as of December 31, 2011, 2010 and 2009 are as follows:

		September 30,			September 30,		September 30,			September 30,		September 30,			September 30,
	December 31,
	2011					2010					2009
	# of Shares			Average Exercise  Price		# of Shares			Average Exercise  Price		# of Shares			Average Exercise  Price
Beginning balance		157,500		$	27.13		191,000		$	26.21		231,750		$	25.62
Granted		—			—		—					—			—
Exercised		(52,250	)	$	22.35		(29,000	)	$	21.12		(40,750	)	$	23.16
Expired or forfeited		—			—		(4,500	)	$	26.69		—			—
Ending balance		105,250		$	29.50		157,500		$	27.13		191,000		$	26.21
Number of options exercisable		105,250		$	29.50		157,500		$	27.13		191,000		$	26.21

Summarized Information about Options Outstanding

The following table summarizes information about options outstanding as of December 31, 2011:

		September 30,		September 30,		September 30,		September 30,		September 30,
Price Range	Outstanding Options		Average Remaining Contract Life		Average Exercise  Price		Exercisable Options		Average Exercise  Price
$21 to $30		83,750		2.0	$	28.51		83,750	$	28.51
$31 to $37		21,500		3.2	$	33.39		21,500	$	33.39
Total		105,250						105,250

SARs Outstanding

SARs outstanding as of December 31, 2011, 2010 and 2009 are as follows:

		September 30,			September 30,		September 30,			September 30,		September 30,			September 30,
	December 31,
	2011					2010					2009
	SARs			Average Exercise Prices		SARs			Average Exercise Prices		SARs			Average Exercise Prices
Beginning balance		16,500		$	18.74		52,000		$	14.05		59,250		$	13.89
Granted		—			—		—			—		—			—
Exercised		(16,500	)	$	18.74		(35,500	)	$	11.86		(7,250	)	$	12.76
Expired or forfeited		—			—		—			—		—			—
Ending balance		—			—		16,500		$	18.74		52,000		$	14.05
Number of SARs exercisable		—			—		16,500		$	18.74		52,000		$	14.05